Tag: UCART19 Lymphoblastic Leukemia Drug

Servier, Pfizer given FDA green signal for lymphoblastic leukemia drug

pharmanewsdaily- March 12, 2017

The US Food and Drug Administration (FDA) has given the green signal to Servier and Pfizer to carry out the clinical development of their UCART19 ... Read More